Cabaletta Bio, Inc. (CABA)
2.91
-0.36
(-11.01%)
USD |
NASDAQ |
Sep 09, 16:00
2.96
+0.05
(+1.72%)
After-Hours: 04:43
Cabaletta Bio Price to Book Value : 2.318 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 2.318 |
| September 08, 2026 | 2.604 |
| September 04, 2026 | 2.764 |
| September 03, 2026 | 2.772 |
| September 02, 2026 | 2.843 |
| September 01, 2026 | 2.628 |
| August 31, 2026 | 2.477 |
| August 28, 2026 | 2.485 |
| August 27, 2026 | 2.692 |
| August 26, 2026 | 2.588 |
| August 25, 2026 | 2.565 |
| August 24, 2026 | 2.469 |
| August 21, 2026 | 2.493 |
| August 20, 2026 | 2.541 |
| August 19, 2026 | 2.469 |
| August 18, 2026 | 2.318 |
| August 17, 2026 | 2.302 |
| August 14, 2026 | 2.190 |
| August 13, 2026 | 2.158 |
| August 12, 2026 | 2.270 |
| August 11, 2026 | 2.222 |
| August 10, 2026 | 2.230 |
| August 07, 2026 | 2.222 |
| August 06, 2026 | 2.198 |
| August 05, 2026 | 2.158 |
| Date | Value |
|---|---|
| August 04, 2026 | 2.206 |
| August 03, 2026 | 2.142 |
| July 31, 2026 | 2.134 |
| July 30, 2026 | 2.166 |
| July 29, 2026 | 2.087 |
| July 28, 2026 | 2.174 |
| July 27, 2026 | 2.166 |
| July 24, 2026 | 2.142 |
| July 23, 2026 | 2.166 |
| July 22, 2026 | 2.190 |
| July 21, 2026 | 2.246 |
| July 20, 2026 | 2.190 |
| July 17, 2026 | 2.254 |
| July 16, 2026 | 2.126 |
| July 15, 2026 | 2.206 |
| July 14, 2026 | 2.126 |
| July 13, 2026 | 2.202 |
| July 10, 2026 | 2.369 |
| July 09, 2026 | 2.481 |
| July 08, 2026 | 2.493 |
| July 07, 2026 | 2.469 |
| July 06, 2026 | 2.397 |
| July 02, 2026 | 2.541 |
| July 01, 2026 | 2.381 |
| June 30, 2026 | 2.477 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.10 |
| Anika Therapeutics, Inc. | 2.036 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.682 |
Price to Book Value Related Metrics
| Price | 2.91 |
| Earnings Yield | -54.36% |
| Market Cap | 488.08M |